KNSA - CIK 0001730430
Kiniksa Pharmaceuticals, Ltd. has filed 733 documents with the SEC between 2018 and 2026. The most frequent type is insider trade (335 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Proxy statement | DEF 14A | 2024-04-23 | 2024-06-05 |
| Major company event | 8-K | 2024-04-23 | 2024-04-23 |
| PRE 14A | - | 2024-04-10 | 2024-04-10 |
| Insider trade | 4 | 2024-04-08 | 2024-04-04 |
| Insider trade | 4 | 2024-04-08 | 2024-04-04 |
| Insider trade | 4 | 2024-04-08 | 2024-04-04 |
| Insider trade | 4 | 2024-04-08 | 2024-04-04 |
| Insider trade | 4 | 2024-04-08 | 2024-04-04 |
| Insider trade | 4 | 2024-04-08 | 2024-04-04 |
| Insider trade | 4 | 2024-04-03 | 2024-04-01 |
| Insider trade | 4 | 2024-04-03 | 2024-04-01 |
| Insider trade | 4 | 2024-04-03 | 2024-04-01 |
| Insider trade | 4 | 2024-04-03 | 2024-04-01 |
| Insider trade | 4 | 2024-04-03 | 2024-04-01 |
| Insider trade | 4 | 2024-04-03 | 2024-04-01 |
| Major company event | 8-K | 2024-04-02 | 2024-04-02 |
| Proxy materials | DEFA14A | 2024-03-29 | - |
| Proxy materials | DEFA14A | 2024-03-29 | - |
| Major company event | 8-K | 2024-03-29 | 2024-03-29 |
| Insider trade | 4 | 2024-03-11 | 2024-03-07 |
| Insider trade | 4 | 2024-03-06 | 2024-03-04 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider sale notice | 144 | 2024-03-04 | - |
| Insider sale notice | 144 | 2024-03-01 | - |
| Insider trade | 4 | 2024-03-01 | 2024-02-28 |
| Insider trade | 4 | 2024-02-29 | 2024-02-27 |
| Insider sale notice | 144 | 2024-02-28 | - |
| Annual report | 10-K | 2024-02-28 | 2023-12-31 |
| Employee stock plan | S-8 | 2024-02-28 | - |
| Major company event | 8-K | 2024-02-28 | 2024-02-28 |
| Insider sale notice | 144 | 2024-02-27 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| Passive ownership stake | SC 13G | 2024-02-12 | - |
| Passive ownership stake | SC 13G | 2024-01-25 | - |
| Insider trade | 4 | 2024-01-04 | 2024-01-03 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Major company event | 8-K | 2024-01-04 | 2024-01-04 |
| Insider sale notice | 144 | 2024-01-03 | - |
| SEC correspondence | UPLOAD | 2024-01-02 | - |
| Insider trade | 4 | 2023-12-21 | 2023-12-19 |
| Insider sale notice | 144 | 2023-12-19 | - |
| Insider trade | 4 | 2023-12-11 | 2023-12-07 |
| Company correspondence | CORRESP | 2023-12-08 | - |
| Insider sale notice | 144 | 2023-12-07 | - |
| Company correspondence | CORRESP | 2023-11-21 | - |
| SEC correspondence | UPLOAD | 2023-11-16 | - |
| Insider trade | 4 | 2023-11-07 | 2023-11-03 |